was successfully added to your cart.

Your SEO optimized title page contents

On Monday, the Feds called "their guy" in Mississippi and let him know they would need a few more pounds than they did last year. The order, on behalf of the National Institute on Drug Abuse(NIDA), asked for 1,430 pounds of medicinal grade cannabis from the University of Mississippi. That is more than 30 times the amount they originally ordered for 2014!

What is driving this demand for more research? It may have something to do with what is going on in Colorado and Washington. In addition to those two states and the 20+ medicinal programs around the country, the sentiment and approval for marijuana reform is here and is no longer able to be kept quiet. Many realize the plant's medicinal benefits, but federal laws keep those that are interested in doing research legally, in the dark.

The marijuana requested will be used in research studies funded by the federal government and performed by the NIDA. In order to continue to properly reform the antiquated marijuana laws in this country, research needs to be done. At this point, the Feds are the only ones granted with this privilege. So until they allow others to perform the much needed research, it’s good to see that they are at least increasing the quantity used in the process.

Quantum 9, Inc. is the leading North American Medical Marijuana Consulting firm.

About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

One Comment

  • David W James says:

    We could save the money and time involved in new research by recognizing the many thousands of pages of marijuana research done in other countries.

Leave a Reply